Clearside Biomedical Inc (CLSD) has disclosed a new risk, in the Regulation category.
Clearside Biomedical Inc. operates in a complex legal environment, facing stringent U.S. and foreign export, import controls, and anti-corruption laws. Their ability to compete globally may be hindered by the need to comply with these regulations, which include the U.S. Export Administration Regulations and the Foreign Corrupt Practices Act. The company engages with foreign officials and third-party collaborators, potentially exposing them to liability for acts of corruption by these associates, even without direct knowledge or authorization. Non-compliance could lead to severe penalties, including criminal charges, fines, and reputational damage, threatening Clearside’s operational and financial stability.
The average CLSD stock price target is $5.00, implying 206.75% upside potential.
To learn more about Clearside Biomedical Inc’s risk factors, click here.
